Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Company details
Agendia
Summary
Agendia was established in 2003 to further develop and commercialize MammaPrint® and similar gene expression profiling services. The company, located in Amsterdam, The Netherlands, has a high quality laboratory for patient testing up and running and currently employs 15 people. Several large scale clinical studies are ongoing in hospitals in Europe and the USA to validate MammaPrint® in large and diverse patient populations. Agendia wants to become the leading global gene expression profiling service to all stakeholders in healthcare. The company commits itselt to high standards of integrity in contributing to the best interests of patients, the medical profession, employees and communities, based on the continual pursuit of scientific and operational excellence.
R&D
To view this information, you must subscribe to Partneringtools.
Partnerships
To view this information, you must subscribe to Partneringtools.
Deals
To view this information, you must subscribe to Partneringtools.
Senior management
To view this information, you must subscribe to Partneringtools.
Head office
To view this information, you must subscribe to Partneringtools.
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us